The Marketplace where Innovations Turn Lifespan into Healthspan

Business Design Centre, London | May 9 -10, 2026

VO₂ Max: The #1 Longevity Biomarker and the Breath Test That’s Changing Personalized Health

Gregoris Balamatsias

VO₂ Max: The #1 Longevity Biomarker and the Breath Test That’s Changing Personalized Health

This talk explores how VO₂ max—the strongest predictor of longevity—can be easily and accurately measured through breath analysis. Attendees will learn how PNOĒ's portable metabolic system and ecosystem of services unlock insights into cellular health, fat-burning efficiency, and biological age, enabling clinics to offer hyper-personalized programs that boost outcomes, retention, and revenue. Gregoris Balamatsias is a Lead Expansion Strategist - North America with a dynamic background in wellness, branding, e-commerce, and innovation consulting. Currently leading global outreach initiatives at PNOĒ, he spearheads the company's international expansion and practitioner adoption strategy, including the acclaimed PNOĒ On the Road campaign that brought metabolic testing to over 300 clinics across the U.S. With previous leadership roles at Skroutz S.A., Wunderman Thompson, and Limitless S.a.r.l., Gregoris has helped generate over €37 million in new business revenue and played a pivotal role in scaling brands across European and global markets. He combines a deep understanding of longevity, performance optimization, and health technology with a strategic vision for growth and innovation. He holds a Master’s degree in Entrepreneurship & Innovation from the University of Luxembourg and a Bachelor’s in Sociology from the University of Crete. He is currently completing his second BA in Political Science and Public Administration at the National and Kapodistrian University of Athens.